In healthtech, biotech and research, the data is worth more than the infrastructure holding it, so the bar for who tests it is high. CREST membership is an internationally recognised, independently audited standard that answers the competence and ethical-conduct questions HIPAA-regulated and research organisations have to ask of any external tester.
For health platforms the report maps to HIPAA safeguards and separates clinical-risk findings; for universities and biotech it respects research-data and institutional boundaries agreed at kickoff. Accreditation plus careful test-data governance is what makes high-assurance testing safe in these environments.
Independently audited competence and a documented ethical framework, for PHI-grade trust
Findings mapped to HIPAA safeguards and SOC 2, with clinical- and research-risk separated
Test-data governance agreed up front: what we touch, what gets synthetic data, how evidence is destroyed
Penetration testing is unregulated in most jurisdictions, anyone can call themselves a penetration tester and many providers do. CREST exists specifically to provide a recognised quality signal that buyers can rely on without running their own competency assessments on every vendor.
For regulated sectors, CREST has effectively become a procurement requirement: SOC 2 auditors and enterprise security teams expect independent accreditation; cyber insurers increasingly require it; enterprise security teams use CREST as a vendor pre-qualification filter.
Disqualification from financial sector threat-led testing programmes
Failed enterprise security reviews requiring CREST evidence
Variable test quality across providers without quality framework
Compliance audit findings on penetration testing rigour
Reduced confidence in test results from board and audit committees
Inability to evidence ethical conduct framework to regulators
CREST accreditation is the cheapest way to remove a major variable from your vendor selection, and the strongest external signal of testing quality.
Boston engagements are shaped by data sensitivity: PHI under HIPAA, research IP worth more than the infrastructure holding it, student and financial records. Test-data governance is agreed at kickoff, what we may touch, what gets synthetic data, how evidence is stored and destroyed, and the rules of engagement document it before testing starts.
Delivery runs Eastern hours. Reporting separates clinical- and research-risk findings for the stakeholders who need them, maps to HIPAA safeguards and SOC 2 criteria, and includes an attestation letter for the compliance file.
Scope typically spans the patient- or customer-facing application, its APIs and integrations (EHR, claims, LIMS, identity providers), and the cloud estate underneath. We test authorisation logic hard, because in health and research environments, who can see what is the finding that matters.
Critical findings are flagged same-day through an agreed private channel. Remediated findings are retested inside the fee, and the closure letter is written for the audience that asked, auditor, IRB-adjacent committee, or enterprise client.
Every CREST penetration test with RedSecLabs includes:
We deliver this service across these industries:
Every CREST member company differs in how it delivers within the framework. We staff every engagement with senior CREST-certified testers, never juniors operating under loose supervision, and our reports are explicitly structured to the standard CREST-aware buyers expect. The result is testing that withstands the audit-committee, regulator, and enterprise-security scrutiny our clients put it under.
Book a free 30-minute scoping call. CREST-format proposal within 48 hours, engagement starts within 1-2 weeks.